{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:25Z","timestamp":1785545065460,"version":"3.56.0"},"reference-count":52,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with impaired glucose tolerance (IGT) identified during pregnancy who do not develop gestational diabetes mellitus (GDM) often do not receive additional interventions for their long-term metabolic risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This nonrandomized pre-post implementation study reports the design process and initial program evaluation for Better Follow-up of Impaired Glucose Tolerance (BRIDGE), a 12-week text-based postpartum support program promoting hemoglobin A\n                      <jats:sub>1c<\/jats:sub>\n                      (HbA\n                      <jats:sub>1c<\/jats:sub>\n                      ) completion and primary care provider (PCP) visit scheduling for patients diagnosed with IGT during pregnancy, assessing improvement in desired postpartum transition milestones. The 19-month program was divided into 2 arms lasting 9.5 months each, BRIDGE\u2212 (SMS text messaging support alone; October 2021-July 2022) and BRIDGE+ (SMS text messaging and IGT-focused postpartum visit; July 2022-April 2023). We aimed to assess whether BRIDGE improved desired postpartum transition milestones.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients were eligible for BRIDGE if they received prenatal care at the study site (a northeastern US academic tertiary care center), were diagnosed with IGT during pregnancy, never developed GDM, and could receive English text messages. We performed a program evaluation using a pre\/postimplementation design, comparing outcomes for the BRIDGE population to a 19-month historical population. Primary outcomes were (1) completion of HbA\n                      <jats:sub>1c<\/jats:sub>\n                      testing by 1 year postpartum and (2) PCP visit scheduling by 12 weeks postpartum. A comparative analysis between BRIDGE\u2212 and BRIDGE+ was performed. Multivariable logistic regressions controlled for the history of IGT after stepwise backward elimination.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the program evaluation, 503 individuals were included (n=342 in historical population, n=82 in BRIDGE\u2212 population, and n=79 in BRIDGE+ population), with similar demographic and clinical characteristics across populations. A total of 212 individuals were screened for eligibility in BRIDGE, and 161 individuals participated in the program. BRIDGE participants had increased odds of HbA\n                      <jats:sub>1c<\/jats:sub>\n                      completion by 1 year postpartum (39.8% vs 12.5%; adjusted odds ratio [aOR] 4.28, 95% CI 2.71\u20106.78) and PCP visit scheduling (31.0% vs 12.0%; aOR 9.58, 95% CI 4.39\u201020.9) compared to the historical population. BRIDGE+ patients were more likely to complete HbA\n                      <jats:sub>1c<\/jats:sub>\n                      testing by 12 weeks postpartum than BRIDGE\u2212 participants. Most patients attended scheduled PCP visits, but rates of IGT counseling at PCP visits were low.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Individuals with IGT rarely receive targeted interventions during pregnancy or delivery hospitalization. This innovative study demonstrates that individuals with IGT have high rates of uptake for postpartum SMS text messaging support, which tripled completion rates of HbA\n                      <jats:sub>1c<\/jats:sub>\n                      screening within 1 year postpartum and doubled the scheduling rate for PCP visits by 12 weeks postpartum. While attendance at scheduled PCP visits was very high, &lt;60% of PCP visits included IGT counseling, highlighting key improvement areas in the quality of postpartum transitions to primary care. While a randomized trial is needed to ascertain definitive impact, SMS text messaging support may be an effective tool to improve postpartum transitions of care for this underserved population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/76493","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:15:06Z","timestamp":1777623306000},"page":"e76493-e76493","source":"Crossref","is-referenced-by-count":0,"title":["Text Messaging Support for Patients Diagnosed With Impaired Glucose Tolerance During Pregnancy: Nonrandomized Pre-Post Implementation Study Assessing Impact on Postpartum Transitions of Care"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0687-3668","authenticated-orcid":false,"given":"Natasha R","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-0381","authenticated-orcid":false,"given":"Whitney","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-2312","authenticated-orcid":false,"given":"Celeste","family":"Durnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"11","key":"R1","first-page":"209","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9 Suppl 6","key":"R2","first-page":"S40","volume":"13","author":"Warram","journal-title":"Diabet Med"},{"issue":"6749","key":"R3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/bmj.301.6749.397","article-title":"Impaired glucose tolerance","volume":"301","author":"Yudkin","journal-title":"BMJ"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF00252261","article-title":"The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study","volume":"26","author":"King","journal-title":"Diabetologia"},{"issue":"3","key":"R5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","journal-title":"Diabetes Care"},{"issue":"7","key":"R6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2362.2007.01820.x","article-title":"Lifestyle intervention in individuals with normal versus impaired glucose tolerance","volume":"37","author":"Sch\u00e4fer","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"R7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.numecd.2012.12.005","article-title":"Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study","volume":"23","author":"den Boer","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ogc.2007.03.002","article-title":"The increasing prevalence of diabetes in pregnancy","volume":"34","author":"Hunt","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7201a4","article-title":"QuickStats: percentage of mothers with gestational diabetes,* by maternal age\u2014National Vital Statistics System, United States, 2016 and 2021","volume":"72","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajogmf.2019.02.003","article-title":"Universal early pregnancy glycosylated hemoglobin A1c as an adjunct to Carpenter-Coustan screening: an observational cohort study","volume":"1","author":"Boe","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"25","key":"R11","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1080\/14767058.2021.1914578","article-title":"Universal HbA1c screening and gestational diabetes: a comparison with clinical risk factors","volume":"35","author":"Bender","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"14","key":"R12","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1055\/a-1877-8696","article-title":"Adverse pregnancy outcomes in nondiabetic patients with an elevated early pregnancy HbA1c","volume":"29","author":"Bender","journal-title":"Am J Perinatol"},{"issue":"11","key":"R13","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.2337\/dc14-1312","article-title":"An early pregnancy HbA1c \u22655.9% (41 mmol\/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes","volume":"37","author":"Hughes","journal-title":"Diabetes Care"},{"issue":"6A","key":"R14","doi-asserted-by":"publisher","first-page":"16H","DOI":"10.1016\/s0002-9149(01)01832-x","article-title":"Impaired glucose tolerance as a disease","volume":"88","author":"Baron","journal-title":"Am J Cardiol"},{"issue":"7","key":"R15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.22500","article-title":"Postpartum primary care engagement using default scheduling and tailored messaging: a randomized clinical trial","volume":"7","author":"Clapp","journal-title":"JAMA Netw Open"},{"issue":"2","key":"R16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/GRF.0000000000000609","article-title":"Text messaging as a means to engage patients in the postpartum period","volume":"64","author":"Gomez","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","DOI":"10.3390\/nu16060821","article-title":"Effect of the rs2821557 polymorphism of the human Kv1.3 gene on olfactory function and BMI in different age groups","volume":"16","author":"Melis","journal-title":"Nutrients"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-92","article-title":"The DIAMIND study: postpartum SMS reminders to women who have had gestational diabetes mellitus to test for type 2 diabetes: a randomised controlled trial\u2014study protocol","volume":"13","author":"Heatley","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.pec.2018.10.028","article-title":"Evaluating the use of text message communication in a postpartum patient navigation program for publicly insured women","volume":"102","author":"Strohbach","journal-title":"Patient Educ Couns"},{"issue":"11","key":"R20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/bmjqs-2018-007837","article-title":"Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial","volume":"27","author":"Hirshberg","journal-title":"BMJ Qual Saf"},{"issue":"7","key":"R21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/jamacardio.2016.2374","article-title":"Participation rates with opt-out enrollment in a remote monitoring intervention for patients with myocardial infarction","volume":"1","author":"Mehta","journal-title":"JAMA Cardiol"},{"issue":"22","key":"R22","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1414293","article-title":"Randomized trial of four financial-incentive programs for smoking cessation","volume":"372","author":"Halpern","journal-title":"N Engl J Med"},{"issue":"18","key":"R23","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1001\/jama.2015.14850","article-title":"Effect of financial incentives to physicians, patients, or both on lipid levels: a randomized clinical trial","volume":"314","author":"Asch","journal-title":"JAMA"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2337\/cd23-as01","article-title":"Standards of care in diabetes-2023 abridged for primary care providers","volume":"41","author":"American Diabetes Association","journal-title":"Clin Diabetes"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000445","article-title":"Follow-up after gestational diabetes: a fixable gap in women\u2019s preventive healthcare","volume":"5","author":"Bernstein","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","journal-title":"BMJ"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-019-0499-1","article-title":"Guidelines for reporting non-randomised pilot and feasibility studies","volume":"5","author":"Lancaster","journal-title":"Pilot Feasibility Stud"},{"issue":"2","key":"R28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jogc.2021.07.018","article-title":"Evaluation of a postpartum cardiovascular risk screening clinic: an analysis of interpregnancy and subsequent pregnancy outcomes","volume":"44","author":"Flatt","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13669-022-00343-6","article-title":"Best practices for managing postpartum hypertension","volume":"11","author":"Kumar","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.colegn.2015.01.001","article-title":"Educational and intervention programmes for gestational diabetes mellitus (GDM) management: an integrative review","volume":"23","author":"Carolan-Olah","journal-title":"Collegian"},{"issue":"8","key":"R31","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1111\/jog.14868","article-title":"Strategies to improve postpartum glucose screening rates are needed","volume":"47","author":"Farid","journal-title":"J Obstet Gynaecol Res"},{"issue":"7","key":"R32","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14861","article-title":"Postpartum screening of women with GDM in specialised practices: data from 12,991 women in the GestDiab register","volume":"39","author":"Linnenkamp","journal-title":"Diabet Med"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/AOG.0000000000001467","article-title":"Variation in postpartum glycemic screening in women with a history of gestational diabetes mellitus","volume":"128","author":"Eggleston","journal-title":"Obstet Gynecol"},{"issue":"4","key":"R34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1055\/s-0037-1607284","article-title":"Barriers to postpartum follow-up and glucose tolerance testing in women with gestational diabetes mellitus","volume":"35","author":"Battarbee","journal-title":"Am J Perinatol"},{"issue":"4","key":"R35","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s11606-013-2744-2","article-title":"Utilization of primary and obstetric care after medically complicated pregnancies: an analysis of medical claims data","volume":"29","author":"Bennett","journal-title":"J Gen Intern Med"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1334-2","article-title":"The forgotten risk? A systematic review of the effect of reminder systems for postpartum screening for type 2 diabetes in women with previous gestational diabetes","volume":"8","author":"Jeppesen","journal-title":"BMC Res Notes"},{"issue":"3","key":"R37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009578.pub2","article-title":"Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance","volume":"2014","author":"Middleton","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"R38","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06569-z","article-title":"How do reminder systems in follow-up screening for women with previous gestational diabetes work?\u2014A realist review","volume":"21","author":"Nielsen","journal-title":"BMC Health Serv Res"},{"issue":"3 Suppl","key":"R39","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.5694\/mja14.00264","article-title":"Primary care of women after gestational diabetes mellitus: mapping the evidence-practice gap","volume":"201","author":"Wilkinson","journal-title":"Med J Aust"},{"issue":"10","key":"R40","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.2337\/dc07-0435","article-title":"Preventive counseling among women with histories of gestational diabetes mellitus","volume":"30","author":"Kim","journal-title":"Diabetes Care"},{"issue":"3","key":"R41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ajog.2017.04.033","article-title":"Optimizing postpartum care for the patient with gestational diabetes mellitus","volume":"217","author":"Martinez","journal-title":"Am J Obstet Gynecol"},{"issue":"707","key":"R42","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.3399\/BJGP.2020.0928","article-title":"Barriers to postpartum diabetes screening: a qualitative synthesis of clinicians\u2019 views","volume":"71","author":"Lithgow","journal-title":"Br J Gen Pract"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-14-41","article-title":"From screening to postpartum follow-up\u2014the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review","volume":"14","author":"Nielsen","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"R44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.whi.2019.08.003","article-title":"Interrupting the pathway from gestational diabetes mellitus to type 2 diabetes: the role of primary care","volume":"29","author":"McCloskey","journal-title":"Womens Health Issues"},{"issue":"1","key":"R45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.37765\/ajmc.2022.88771","article-title":"Telemedicine catches on: changes in the utilization of telemedicine services during the COVID-19 pandemic","volume":"28","author":"Friedman","journal-title":"Am J Manag Care"},{"issue":"2","key":"R46","doi-asserted-by":"publisher","first-page":"100831","DOI":"10.1016\/j.ajogmf.2022.100831","article-title":"Assessing the impact of telehealth implementation on postpartum outcomes for Black birthing people","volume":"5","author":"Kumar","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2","key":"R47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/CAT.23.0343","article-title":"THEA: prenatal education and remote blood pressure monitoring","volume":"5","author":"Graseck","journal-title":"NEJM Catal Innov Care Deliv"},{"issue":"11","key":"R48","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00965-x","article-title":"Asking the right questions-human factors considerations for telemedicine design","volume":"20","author":"Fouquet","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"R49","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project","volume":"10","author":"Powell","journal-title":"Implement Sci"},{"issue":"2","key":"R50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"R51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","journal-title":"Med Care"},{"issue":"1","key":"R52","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16388-y","article-title":"Implementing text-messaging to support and enhance delivery of health behavior change interventions in low- to middle-income countries: case study of the Lifestyle Africa intervention","volume":"23","author":"Materia","journal-title":"BMC Public Health"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2026\/1\/e76493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:27:00Z","timestamp":1785536820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e76493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":52,"URL":"https:\/\/doi.org\/10.2196\/76493","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"v28i11e76493"}}